Critical role for the docking-protein FRS2α in FGF receptor-mediated signal transduction pathways

• DOI: 10.1073/pnas.161259898
• Publication Date: 2002-07-26T14:34:10Z
• Authors: Y. R. Hadari; N. Gotoh; H. Kouhara; I. Lax; J. Schlessinger
• Keywords: 0301 basic medicine; Membrane Proteins; Phosphoproteins; Receptors, Fibroblast Growth Factor; Cell Line; Mice; Phosphatidylinositol 3-Kinases; 03 medical and health sciences; Cell Movement; Animals; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Mitogen-Activated Protein Kinases; Cell Division; Adaptor Proteins, Signal Transducing; Signal Transduction

The docking protein FRS2α has been implicated as a mediator of signaling via fibroblast growth factor receptors (FGFRs). We have demonstrated that targeted disruption of FRS2α gene causes severe impairment in mouse development resulting in embryonal lethality at E7.0–E7.5. Experiments with FRS2α-deficient fibroblasts demonstrate that FRS2α plays a critical role in FGF-induced mitogen-activated protein (MAP) kinase stimulation, phosphatidylinositol-3 (PI-3) kinase activation, chemotactic response, and cell proliferation. Following FGF stimulation, tyrosine phosphorylated FRS2α functions as a site for coordinated assembly of a multiprotein complex that includes Gab1 and the effector proteins that are recruited by this docking protein. Furthermore, we demonstrate that different tyrosine phosphorylation sites on FRS2α are responsible for mediating different FGF-induced biological responses. These experiments establish the central role of FRS2α in signaling via FGFRs and demonstrate that FRS2α mediates multiple FGFR-dependent signaling pathways critical for embryonic development.